Info banner

A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Tag: diabetes

8 posts found

Medmonitor

CMS Drug Pricing Negotiation to Lower Costs of 15 Drugs

The 2025 negotiations covered drugs for obesity, cancer, diabetes, COPD, asthma, and more.

Clinical Insights

JAMA Study Notes Possible Cardiovascular Benefits for GLP-1 Antagonists

Patients taking semaglutide or tirzepatide had a more than 40% lower risk of hospitalization for heart failure compared with patients taking drugs to lower blood sugar.

Medmonitor

FDA Requires New Kidney Injury Warning for All GLP-1 Drugs

Dehydration from these drugs can lead to kidney damage, requiring hemodialysis treatment.

Healthe Developments

Diabetes Complicates Claims, Worker Recovery

Healthe’s VP of Clinical Services, Silvia Sacalis, BS, PharmD, shares her thoughts with Business Insurance in this recent article.

Medmonitor

FDA Approves Generic GLP-1 Victoza Injections for Type 2 Diabetes

Victoza® (liraglutide) injections are a GLP-1 receptor agonist, a drug class experiencing shortages due to their high demand.

Medmonitor

FDA Evaluates Report of Suicidal Thoughts with GLP-1 Receptor Agonist

While no clear link is established to these obesity and diabetes drugs, the FDA will continue to monitor data.

Medmonitor

New Depression Product and Diabetes Generic Approvals

Exuua was approved for major depressive disorder, while two diabetes medications receive generic approvals.

Medmonitor

FDA Approves Drug That Can Delay Onset of Type 1 Diabetes

Tzield (teplizumab-mzwv) injections can delay onset by several months or years.

Workers' Comp Property and Casualty PBM
Expires 01/01/2028